The ten year survival rates for alveolar echinococcosis of the liver have increased from 10% in the 1960s to about 85% today.1 This is due both to improved surgical and medical treatments concepts' 2 and to early diagnosis using serological methods and radiological imaging techniques. A complete cure, however, can only be achieved in those few patients in which radical surgical resection is feasible. Systemic chemotherapy with albendazole or mebendazole does not usually lead to complete extermination of the larvae, but often prevents further spread of the disease. 2 The development of portal hypertension with ascites is cited in the literature as a frequent complication. This is caused by biliary cirrhosis secondary to infestation of the bile ducts or to stenosis of the portal or hepatic veins in the Budd-Chiari syndrome. In such cases, the creation of a portocaval shunt or surgical resection are usually considered. This is the report of a patient in whom the development of portal hypertension was caused by a dorsally situated focal infestation of the liver with increasing stenosis of the hepatic veins, which we treated with the percutaneous placement of metal mesh stents in the median and left hepatic veins.
Case report A 53 year old white woman had alveolar echinococcosis of the liver with infiltrative growth, encasement of the inferior vena cava, and retroperitoneal spread to the adrenal glands and diaphragm was (Fig 1 B ) demonstrated blood flow in the portal vein. Demonstration by computed tomography of a large, dorsally situated focus of infestation impinging on the hepatic veins and the significantly delayed uptake of contrast medium in the hepatic parenchyma ( Fig 1A) provided evidence of stenosis in the hepatic veins. The stenoses of the median and left hepatic veins was subsequently confirmed by transjugular phlebography of the hepatic veins (Fig 1 C) and verified by the measurement of a prestenotic to poststenotic venous pressure difference of 23 cm H20. The right hepatic vein was completely occluded. (Fig 2A) .
Immediately after placement of the stent, Doppler sonography showed an appreciable increase in portal flow (21 cmlsec), which later increased to 40 cm/s. At a follow up examination one week later, abdominal circumference had decreased to 84 cm and ultrasound showed only discrete remaining ascites.
After a follow up period of 15 months, the patient feels subjectively well. Both Doppler ultrasound and computed tomography continued to show stent patency and there was no discernible ascites. Prothrombin time (Quick) has increased from 48% to 97% and endoscopy shows only grade I oesophageal varices. Discussion Radical surgery is followed by cure in only 200/6-40% of patients with asymptomatic alveolar echinococcosis. Thus surgical procedures are often no more than palliative in nature and an additional, lifelong chemotherapy is required.2 Moreover, postoperative morbidity rates between 14% and 53% have been reported.3 A study by Bresson-Hadni4 reported the results of 17 orthotopic liver transplants in patients with alveolar echinococcosis of the liver. Fifteen of these patients exhibited portal hypertension, which in seven patients was secondary to the Budd-Chiari syndrome with posterior localisation. The remaining four patients had either disease spread to the liver hilus with infiltration of the portal vein or biliary cirrhosis. A second operation was required in a significantly higher proportion of patients with alveolar ecchinococcosis receiving orthotopic liver transplants than in a comparable group without cestode infection and their 15 month survival rate (75% v 89% in the non-infected group) was lower. We reiterate that a curative operation can only be expected in cases of localised infestation. This is usually not seen in patients with posterior localisation, such that operation, as, for example, in the treatment of the life threatening Budd-Chiari syndrome, often has no more than a palliative character. As a rule, the surgical option is confounded by a long history of prior operations and by a high rate of postoperative complications often requiring remedial surgery in their own right. These results lead the authors to the conclusion that interventional radiological methods should be preferred in these patients.
While interventional methods (stent placement, angioplasty, thrombolysis) are often performed in cases of Budd-Chiari syndrome due to membrane stenosis or thrombosis,5 6 we were unable to find any reports of stent placement in cases of hepatic vein stenosis secondary to alveolar echinococcosis. The diagnosis of infiltrating spread of the disease to adjacent organs and into the thorax had already been made in the patient presented in this report. The appearance of ascites with evidence of portal hypertension (oesophageal varices, absence of portal blood flow at Doppler sonography) led us to defer consideration of surgical treatment.
Computed tomography disclosed a large, dorsally situated focus with occlusion of the inferior vena cava, suggesting stenosis of the hepatic veins (Budd-Chiari syndrome), which was later confirmed angiographically. Despite a reduction in liver function, the high pressure gradient across the stenosis augured well for a successful therapeutic outcome after stent placement without creation of an intrahepatic shunt.
Following stent placement, the patient experienced a rapid and sustained reduction of her ascites, so that diuretics could be discontinued. Anticoagulants were also not indicated, since neither a thrombosis nor a coagulopathy had been implicated. The liver values normalised. With the continued treatment with albendazole (400 mg twice daily), there was no evidence of stent occlusion in the 15 month follow up period.
